ArticleRedox biology2017

Specificity protein 1-modulated superoxide dismutase 2 enhances temozolomide resistance in glioblastoma, which is independent of O

Kwang-Yu Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.